High cholesterol and hardening of the arteries remain serious threats to health in China. A group of medical experts has come together to review current practices and offer new guidance. Their goal is simple: to improve how doctors prevent and manage these conditions for people in the Chinese population. The advice focuses on initial strategies to lower cholesterol levels before they cause more damage. This guidance is meant to help healthcare providers make better choices for their patients. The experts did not report specific safety issues or side effects in this consensus statement. They also did not share exact numbers on how many people were involved or how long the review took. Instead, they focused on the overall approach to care. This update aims to fill gaps in knowledge and ensure that treatment plans fit the needs of the local community. By clarifying these steps, the group hopes to reduce heart risks and improve long-term outcomes for those living with these conditions.
New guidelines offer cholesterol strategies for Chinese patients with heart disease
Photo by Enayet Raheem / Unsplash
What this means for you:
Experts in China offer new advice to better manage cholesterol and artery disease for local patients. More on Atherosclerotic Cardiovascular Disease
Narrative review examines metabolic syndrome and novel agents in kidney transplant recipients Kidney transplant patients face high metabolic risks and rejection
Frontiers · May 21, 2026
OAC monotherapy offers optimal balance for secondary prevention in atrial fibrillation and stroke patients compared to combination strategies Taking one blood thinner alone works best for heart and stroke patients compared to mixing medicines
· May 15, 2026
FDA Approves Crestor (rosuvastatin) for Cardiovascular Risk Reduction in Adults FDA approves Crestor to prevent heart attacks and strokes in certain adults.
FDA · May 5, 2026
Sex differences in outcomes after stroke in NVAF with ASCVD: a post hoc analysis Women and Men With AFib and Clogged Arteries Share Same Stroke Risk
· May 2, 2026